BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16384865)

  • 1. Classical genotropic versus kinase-initiated regulation of gene transcription by the estrogen receptor alpha.
    Almeida M; Han L; O'brien CA; Kousteni S; Manolagas SC
    Endocrinology; 2006 Apr; 147(4):1986-96. PubMed ID: 16384865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids.
    Kousteni S; Han L; Chen JR; Almeida M; Plotkin LI; Bellido T; Manolagas SC
    J Clin Invest; 2003 Jun; 111(11):1651-64. PubMed ID: 12782668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor.
    Kousteni S; Almeida M; Han L; Bellido T; Jilka RL; Manolagas SC
    Mol Cell Biol; 2007 Feb; 27(4):1516-30. PubMed ID: 17158928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estren behaves as a weak estrogen rather than a nongenomic selective activator in the mouse uterus.
    Hewitt SC; Collins J; Grissom S; Hamilton K; Korach KS
    Endocrinology; 2006 May; 147(5):2203-14. PubMed ID: 16469803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen.
    Cheng J; Zhang C; Shapiro DJ
    Endocrinology; 2007 Oct; 148(10):4634-41. PubMed ID: 17615152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nongenotropic synthetic ligand 4-estren-3alpha17beta-diol is a high-affinity genotropic androgen receptor agonist.
    Krishnan V; Bullock HA; Yaden BC; Liu M; Barr RJ; Montrose-Rafizadeh C; Chen K; Dodge JA; Bryant HU
    Mol Pharmacol; 2005 Mar; 67(3):744-8. PubMed ID: 15557561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential ERα-mediated rapid estrogenic actions of ginsenoside Rg1 and estren in human breast cancer MCF-7 cells.
    Gao QG; Chan HY; Man CW; Wong MS
    J Steroid Biochem Mol Biol; 2014 May; 141():104-12. PubMed ID: 24508513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estren is a selective estrogen receptor modulator with transcriptional activity.
    Movérare S; Dahllund J; Andersson N; Islander U; Carlsten H; Gustafsson JA; Nilsson S; Ohlsson C
    Mol Pharmacol; 2003 Dec; 64(6):1428-33. PubMed ID: 14645673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estren (4-estren-3alpha,17beta-diol) is a prohormone that regulates both androgenic and estrogenic transcriptional effects through the androgen receptor.
    Centrella M; McCarthy TL; Chang WZ; Labaree DC; Hochberg RB
    Mol Endocrinol; 2004 May; 18(5):1120-30. PubMed ID: 14764654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma membrane estrogen receptors exist and functions as dimers.
    Razandi M; Pedram A; Merchenthaler I; Greene GL; Levin ER
    Mol Endocrinol; 2004 Dec; 18(12):2854-65. PubMed ID: 15231873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estren-mediated inhibition of T lymphopoiesis is estrogen receptor-independent whereas its suppression of T cell-mediated inflammation is estrogen receptor-dependent.
    Islander U; Erlandsson MC; Chavoshi T; Jochems C; Movérare S; Nilsson S; Ohlsson C; Gustafsson JA; Carlsten H
    Clin Exp Immunol; 2005 Feb; 139(2):210-5. PubMed ID: 15654819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.
    Monroe DG; Getz BJ; Johnsen SA; Riggs BL; Khosla S; Spelsberg TC
    J Cell Biochem; 2003 Oct; 90(2):315-26. PubMed ID: 14505348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor DNA binding is not required for estrogen-induced breast cell growth.
    DeNardo DG; Cuba VL; Kim H; Wu K; Lee AV; Brown PH
    Mol Cell Endocrinol; 2007 Oct; 277(1-2):13-25. PubMed ID: 17825481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
    Petz LN; Ziegler YS; Schultz JR; Nardulli AM
    Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors.
    Stossi F; Barnett DH; Frasor J; Komm B; Lyttle CR; Katzenellenbogen BS
    Endocrinology; 2004 Jul; 145(7):3473-86. PubMed ID: 15033914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.